Background
Asthma is one of the most common chronic respiratory diseases, and although there is no cure, there is a great deal of ongoing research to develop a solution. The symptoms of Asthma, such as wheezing, a tight chest, and a persistent cough, make it difficult to carry out daily activities. For many, their quality of life is significantly reduced. Asthma is characterized by chronic inflammation of the airways. Current treatment options rely on controlling the symptoms of inflammation. There are currently a number of innovative cellular therapies available that utilize UC-MSCs, which have the capacity to regulate the immune system. While there is no cure for Asthma, there is a great deal of potential to develop advanced therapies to repair the damage caused to the airways using the techniques found in the field of Regenerative Medicine Thailand.
Asthma Pathophysiology
Asthma is characterized by the inflammation of the bronchial tubes. After coming into contact with an allergen, the immune system reacts by T-helper 2 cells releasing the cytokines IL-4, IL-5, IL-13, etc., which then infiltrate the airway mucosa and its surrounding tissues, where they recruit eosinophils and mast cells. Prolonged and unaddressed inflammation will lead to irreversible changes (known as airway remodeling) such as fibrosis of the airway wall and hypertrophy of the surrounding smooth muscle and epithelium, which will increase the increase the narrowing of the airways. To address this, Regenerative Medicine Thailand is actively investigating the use of UC-MSCs. Breathing becomes almost impossible due to airflow obstruction, a severe Asthma symptom that Regenerative Medicine Thailand aims to reverse using UC-MSCs.
Traditional Asthma Treatment
Symptoms of Asthma are chronic, and the current clinical methods involve the use of multiple drugs in a treatment regimen. The main component of an Asthma regimen is the use of inhaled corticosteroids, which are aimed to decrease the inflammation in the airways, and short-acting β-agonists to provide emergency relief of bronchospasm. An even more complex regimen is required for the treatment of severe, stubborn Asthma. The complex regimen of prescribed medications is required even with the side effects of the medications. Prolonged medication of corticosteroids leads to the side effects of early osteoporosis, disturbance in the immune system, and disturbance of metabolism. In addition to the systemic side effects, the conventional medications do not remodel the airways or the biological aspects of the disease, unlike UC-MSCs. The disease still remains, and the patient is required to take the medications for the entire duration of their lives. While a complex regimen does offer symptomatic relief, and is required for the treatment of the disease, it also causes a high medication tolerance, which leaves the patient vulnerable and exposed to a life-threatening Asthma attack, highlighting the urgent need for Regenerative Medicine Thailand.
Why Use UC-MSCs Instead ?
When compared to conventional medications for the management of symptoms, a cell-based approach within Regenerative Medicine Thailand offers even more benefits. The UC-MSCs are a great option for the treatment of Asthma due to their capabilities for tissue repair and immunomodulation. When injury occurs to the tissue of the lung, UC-MSCs can migrate to the site of inflammation and injury, and begin the repair process through the secretion of paracrine factors. In addition to the paracrine factors, UC-MSCs can inhibit the activities of T-helper 2 cells. If these cells are overactive and promote inflammation, UC-MSCs can downregulate their activities and also promote the formation of T-reg cells. T-reg cells can create a calm and balanced environment for the lung tissue and can promote an overall healthy state, promote overall lung homeostasis that has been inflamed for a long period of time. UC-MSCs are also able to stop the remodeling of airways. They create important antifibrotic proteins that break down excess collagen held in the subepithelial layer of Asthma patients. The exosomes they secrete stimulate the rapid regeneration of healthy alveolar epithelial cells and restoration of the protective mucosal barrier. By controlling overactive immune response and structural repair, UC-MSCs successfully implement a healing process championed by Regenerative Medicine Thailand.
Figure 1: Comparing Traditional treatment and Regenerative Cell-based Approach
Trends and Future in Thailand
Regenerative medicine is an area of rapidly advancing therapeutic options around the world, and Thailand has strategically and intentionally committed considerable resources and plans to position themselves at the cutting edge of modern biotechnologies. The considerable investment into Thailand’s advanced biomedical infrastructure includes advanced laboratory and clinic facilities, ethically-oriented biomedical clinical research staff, and clinical research. Thai researchers have developed tailored protocols to selectively cultivate umbilical cord-derived mesenchymal stem cells (UC-MSCs), which ensures high cellular viability and therapeutic potency. The high level of integration of cutting-edge biotechnologies with high quality localized medical practice in Thailand enables accelerated therapeutic translational practice for MSCs. The large number of extensive and detailed clinical trials currently underway to assess the safety and therapeutic efficacy of cellular therapies will position Thailand within the global market for regenerative medicine.
Conclusion
It is evident that with limitations on the quality of life that Asthma carries as a life-long medical condition, there are no conventional pharmacological treatments that reverse its pathology. The ingenious use of UC-MSCs and Regenerative Medicine in Thailand has the capacity to alter the specialization of the field of pulmonology in a positive and productive manner. With regard to the diseases caused by Asthma, the employed multipotent UC-MSCs can target the impairment of the immune system, remove damaging fibrotic lesions, and help to regenerate the damaged tissues. The innovative progression of Regenerative Medicine Thailand has established robust clinical frameworks, from which these safe treatments can be delivered with precision. Continuing to implement this cellular paradigm will reshape the global approach to the treatment of chronic respiratory disease. The transition to this biological framework will signify an unprecedented advance to free impacted patient populations from the respiratory constraints associated with these conditions.